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Retrovirus are unique because they present two complete copies of the genomic RNA in each virion. It is believed that only one proviral
DNA is formed from the two genomic RNAs. To check this hypothesis, we constructed two deleterious HIV-1 variants in gag gene which
upon transfection in Cos-1 cells were able, by complementation, to form heterozygous viruses, used to infect MT4 cells in a plaque assay.
Analysis of the proviral DNA of the eight plaques obtained indicated that five were recombinants between the two deleterious mutants. Three
other plaques showed three bands corresponding to the reverse transcription of both strands of one heterozygous virion and to the
recombination of the two genomes. These results demonstrate that the two genomic RNAs in HIV-1 heterozygous virions could be used in
the generation of new viruses. This mechanism permits the recovery of deleterious mutants and enhances the evolutive potential of HIV-1.
D 2005 Elsevier Inc. All rights reserved.
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Retrovirus contains two complete copies of the genomic
RNA in each viral particle (Coffin et al., 1997; Temin and
Mizutani, 1970). The retroviral life cycle requires the
conversion of the genomic RNA into a DNA copy, which
is integrated into the host genome, for the generation of new
viruses (Temin, 1976). One retroviral RNA is sufficient for
synthesis of one proviral DNA (Jones et al., 1994), and it
has been proposed that only one DNA copy is produced
from the two copies of the genomic RNA (Coffin et al.,
1997; Hu and Temin, 1990a; Panganiban and Fiore, 1988;
Steffen and Weinberg, 1978). This characteristic led to the
definition of retroviruses as pseudo-diploid organisms (Hu
and Temin, 1990b).
What is the role of the two genomic RNAs in
retroviruses? It is clear that the mayor function of the
second strand is to contribute to the extensive recombination
observed in retrovirus (Coffin, 1979; Jetzt et al., 2000;
Kellam and Larder, 1995; Moutouh et al., 1996; Temin,0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: clopez@isciii.es (C. Lo´pez-Galı´ndez).1993) and HIV-1 (McCutchan, 2000). Two models have
been proposed to explain genetic recombination during
reverse transcription and are summarized in Fig. 1. In the
copy choice model, genetic recombination occurs during the
minus-strands DNA synthesis (Coffin, 1979; Xu and Boeke,
1987, #6088). In the strand displacement-assimilation
model, recombination occurs during the plus DNA syn-
thesis. In this model, recombination requires two minus-
strand DNA copies (DeStefano et al., 1992; Hsu and Taylor,
1982; Hunter, 1978; Junghans et al., 1982; Skalka et al.,
1982; Weiss et al., 1973; Whiting and Champoux, 1994).
Although most of the retroviral recombination occurs during
the minus-strand synthesis (Li and Zhang, 2000), these two
models are not mutually exclusive, and there is experimental
support for both models (Goodrich and Duesberg, 1990; Hu
and Temin, 1990b; Stuhlmann and Berg, 1992; Zhuang et
al., 2002).
Plaque assays have been extensively used in several viral
systems to quantitate viral stocks but also to isolate and
analyze individual biological clones (Luria et al., 1978). It is
assumed that plaques are the result of the infection of the
initial cell by a single virus. This technique permits the
isolation and characterization of biological clones from viral
populations.05) 316–323
Fig. 1. Scheme of the two models proposed to explain genetic recombination during reverse transcription. (A) In the copy choice model, recombination is
consequence of the breaks in one RNA genome. The minus DNA strand stops at the break and switches to the other RNA. The plus-strand DNA is a copy o
the recombinant genome. (B) The displacement assimilation model proposes that two minus DNA strands are synthesized by using both RNA templates
Recombination occurs during plus-strand synthesis, by strand displacement, and assimilation of single-strand DNA tails. The result is a recombinant DNA
strand plus parental strand.
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two provirus from one virion of the human immunodefi-
ciency virus type 1 (HIV-1) using a plaque assay as a
detection system. We obtained heterozygous virions by
complementation between two deleterious mutants from an
HIV-1 molecular clone. The infection of MT-4 cells with
these heterozygous viruses resulted in the formation of
plaques with more than one provirus. Because in our
experimental conditions co-infection was minimized, we
deduced that the integration of two provirus and the
generation of two viruses from a single virion is possible.Results
Analysis on the formation of one HIV-1 plaque in MT-4 cells
HIV-1 plaques in MT4 cells consist in an accumulation
of infected cells above the monolayer as can be seen under
the microscope. They appear around five or 6 days
postinfection. To understand and quantify the process of
formation of one plaque in the MT-4 assay, we carried out
different estimations. First, the number of cells included in a
plaque were counted. The mean value (from seven plaques
analyzed) was in the order of 103 cells.
On the other hand, the average plaque forming units
(p.f.u.) resulting from a plaque in our experiments was 104 a
105 p.f.u. Theoretically one plaque is originated by the
infection of the initial cell by a single virus (Harada et al.,f
.1985) and assuming a burst size of 100, we could deduced
that the formation of one plaque requires a minimum of two
replication cycles.
The analysis of the plaque progenie was performed as
described in Materials and methods analyzing by PCR the
proviral DNA recovered from the cells of the plaque in gag
gene.
Plaques containing two different integrated genomes
In previous experiments to study in vitro genetic
recombination (Iglesias-Sanchez and Lopez-Galindez,
2002), we performed double infections of MT4 cells in liquid
medium with two different strains (LAI and 92UG24,
belonging to subtypes B and D, respectively). By the MT-4
plaque assay, we isolated biological clones from these
supernatants. The majority of the plaques showed two bands
corresponding to the infection of one cell by one virion. But
some plaques displayed three or four bands (see plaques 1 and
5 in the top gel and plaques 2, 4 and 3 in the bottom gels of
Fig. 2). Three hypothesis can explain the formation of these
plaques: (1) The plaques could be originated by the occa-
sional infection by two different viruses of two neighbor cells
included in the same visible plaque. We named these plaques
bdouble-infected plaquesQ. (2) One cell can be infected
simultaneously or bco-infectedQ by two different viruses.
(3) One cell could be infected by a heterozygous virion.
According to the first hypothesis, each cell will harbor
only one parental provirus and only parental virions will be
Fig. 2. Detection of plaques in MT-4 cell monolayer showing two HIV-1
genomes. In double infections of MT4 cells in liquid medium with two
different strains (LAI and 92UG24, belonging to subtypes B and D,
respectively), we isolated biological clones from these supernatants by the
MT-4 plaque assay (see Materials and methods). The parental viruses
presented two bands corresponding to two fragments of different size in
gag and env gene and are designated by B and D on top of the gel. Lanes
designated 1 to 5 correspond to plaques with more than one proviral
genome. Plaques 1 and 2 displayed the two parental genomes, and plaques
3, 4, and 5 correspond to a recombinant plus a parental provirus. A  174
identify the DNA marker.
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virions will be recovered. In the third hypothesis, if both
strands are retrotranscribed, the two parental proviruses will
be integrated.
Differentiation of double-infected versus co-infected plaques
To try to differentiate double-infected plaques from co-
infected plaques, we performed a preliminary experiment.
Two supernatants containing virus LAI and UG24 were
mixed at a 1:1 proportion, and the mix was used to infect a
MT4 cell monolayer at the m.o.i. used in the plaque assay,
6  106. We picked up the 127 plaques obtained and
analyzed their DNA. 126 displayed only one proviral
genome (two bands) but one plaque (number 2 in Fig.
3A) showed two different genomes (four bands). This
plaque could be the result of either a bdouble-infected
plaqueQ or a bco-infectedQ one.Fig. 3. Analysis of the progeny of one HIV-1 plaque with multiple bands. The band
D in the gels. (A) Gel, we can observe the PCR products in gag gene (see Materia
mixture of two viruses (LAI belonging to subtype B, and UG24 from subtype D).
indicating the presence of two integrated proviruses, among the 127 plaques recov
the 98 progeny plaques obtained and analyzed from the infection of plaque 2 in the
of one of the parental provirus indicating that co-infection did not occur. A identThese two possibilities could be resolved analyzing the
progeny of the plaque in a second plaque assay. When a cell
is co-infected by two different viruses, it could yield
heterozygous virions that will give rise to recombinant
viruses. But this will not occur with double-infected plaques
where only parental viruses will be obtained. In Fig. 3B we
can see the result of the analysis by PCR of the progeny of
the plaque with multiple bands. 98 plaques were analyzed
and all of them showed one of the parental provirus, but no
recombinant provirus was detected. Then, the initial plaque
was a bdouble-infected plaqueQ.
Furthermore, to complete this study, we analyzed five
other plaques with a multiple band pattern recovered in
previous experiments of MT4 cells infected with two HIV-1
strains (Iglesias-Sanchez and Lopez-Galindez, 2002). After
analyzing 65, 26, 18, 10, and 10 progeny plaques from the
five plaques, only the parental proviruses were detected. We
never found recombinant plaques in the progeny. In
summary, in all the experiments performed in the same
experimental conditions in this and prior studies, the plaques
with multiple bands are the result of double infection.
Experimental model to study the retrotranscription of the
two genomic RNA
From these studies one question arose, can one virion
integrate the two genomic RNAs and give rise to two
different viruses? To answer this question, we needed a
system which select only for heterozygous virions. To this
end we constructed two different defective HIV-1 genomes,
with deletions in gag gene. In this system, only hetero-
zygous virions will be able to form a plaque by two
mechanisms: (1) recombination of the two deleterious
mutants to produce a genome without deletions; and (2)
complementation between the two different deleted
genomes to form competent viruses.
The two deleterious mutants were synthesized by
deleting two important fragments in gag gene, one in p24
capsid protein and the other in p6 protein. The deletions are
shown in Fig. 4. pDp24 has a deletion of 258 nt (86pattern of the two parental strains of subtypes B and D are designated B and
ls and methods) of the plaque assay from the infection of MT-4 cells with a
(A) Gel, we detected only one plaque (number 2 in the gel) with four bands
ered which showed only one parental provirus. (B) The gels display part of
top gel. All the progeny plaques of this infection, displayed the band pattern
ifies the A  174 DNA marker.
Fig. 5. Scheme of the co-transfections experiments performed in the study.
In line 1 are depicted the two plasmids which produce by cotransfection in
Cos-1 cells a wild-type virus. Plasmid pFAM4 include the 5V end of the
genome until an EcoRI site in position 5324, and pFc correspond from this
EcoRI position to the 3V end of the genome. The supernatants were
concentrated by ultracentrifugation and submitted to an MT-4 plaque assay
as indicated in Materials and methods. The number of plaques recovered is
shown in the column on the right. Line 2 represented the cotransfection of
Dp24 deletion mutant derived from plasmid pFAM4 as described in
Materials and methods and the pFc plasmid. No plaques were obtained in
this cotransfection. Line 3 described the cotransfection of mutant pFDp6
together with pFc which did not produce any viable virus. Line 4
represented the co-transfection experiment with the two deleterious mutants
pFDp24 and pFDp6: The supernatants of three independent transfections
after concentration and infection of MT-4 cells produced 8 plaques.
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A domain implicated in infectivity and viral maturation,
and the major homology region domain (MHR) implicated
in the formation of dimeric proteins, in the gag–gag
interactions and in encapsidation (Freed, 1998). Dp6 is a
33 amino acid deletion from residue 7 to 39, suppressing
the PTAP motif (L domain) which affects particle budding
and the Vpr binding sequence from amino acids 32 to 39.
The deleterious nature of these mutants was checked by co-
transfection into Cos-1 cells and the supernatants used to
infect MT4 cell, resulting in the absence of plaques (see
Fig. 5).
Generation of heterozygous virions
The first step for the analysis of the feasibility of the
reverse transcription of the two HIV-1 genomic RNAs was
the formation of heterozygous virions. To produce these
virions, the two deleterious HIV-1 variants described in the
previous paragraph were cotransfected in Cos-1 cells and
the supernatant used to infect an MT-4 cells monolayer. The
generation of the heterozygous virions was deduced from
the formation of plaques (see Fig. 5). When the trans-
fections were performed with the wild-type positive control
(pFAM + pFC; tube 1) 1500 F 100 plaques were counted.
But when the co-transfection was carried out with the two
deleterious mutants eight plaques were obtained. All these
results are summarized in Fig. 5.
Analysis of the plaques obtained from the infection with
heterozygous virions
The eight plaques obtained in the plaque assay were
picked up and the proviral DNA studied in gag gene. The
result of this test is shown in Fig. 6. Five plaques (numbers
4, 5, 6, 7, and 8) displayed a single band identical to the wt
virus. This band is the result of the recombination of the two
deleterious mutants reconstructing the wild-type genome.Fig. 4. Schematic representation of the deleterious mutants generated in the study.
shows the Gag proteins, and the line below explains the deletions performed. The d
Major structural and functional motifs affected by the deletions in these proteinsBut three plaques (numbers 1, 2, and 3) showed three
bands corresponding to the two defective genomes (lower
bands) and to the wild-type genotype. It is extremely
unlikely that these plaques are the result of three co-
infection events. Furthermore, in our system, the infection
of two neighbor cells by two homozygous viruses will not
result in the formation of a plaque because both mutants
were deleterious. Then, the only possibility to explain these
plaques is the reverse transcription of the two RNA strands
from one virion as explained in Fig. 7. As it is shown, the
first infection cycle in the plaque assay in MT-4 cells with
heterozygous virions will result in the formation of the twoThe genomic organization of the HIV-1 is shown at the top. The middle row
eleted amino acid sequences of p24 protein and p6 protein are shown below.
are indicated.
Fig. 6. PCR analysis in gag gene of the proviruses recovered from MT-4 plaques produced by infection with supernatants of the cotransfection experiment with
the two deleterious mutants. Proviral DNA recovered from the plaques from the cotransfection shown in line 4 of Fig. 5 was amplified by PCR in gag gene
with primers indicated in Materials and methods. The amplicons were resolved in a 0.9 TAE agarose gel. A  174 lane displays the HindIII digestion of A 
174 DNA. Lane Dp24 displays the size band of the p24 mutant and the next one of the Dp6 mutant. The number above the gel identify the plaque. Plaques
numbers 1, 2, and 3 showed three bands corresponding to the two defective genomes (lower bands) and to the wild-type genotype. Plaques numbers 4, 5, 6, 7,
and 8 displayed a single band identical to the wt virus.
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heterozygous virions. However, the two homozygous
virions are not able to form plaques (see Fig. 5). In contrast,
the heterozygous virion will perform a new infection cycle
and will result in the generation of recombinant viruses
displayed in the last line of the figure.Fig. 7. Proposed mechanism for the generation of MT-4 plaques showing
three bands in Fig. 6. In the first cycle of viral replication for the generation
of a plaque in MT-4 cells, a heterozygous virion, produced from co-
transfection experiments with the two deleterious Gag protein mutants
(shown in Fig. 4), infect an MT-4 cell. This heterozygous virion could
generate two different proviruses as depicted in the top cell and will
produce the two lower bands in the gel in the right part of the figure. From
these proviruses three different virions can be produced, the two
homozygous viruses, which are deleterious do not form new plaques as
can be seen in Fig. 5 (lines 2 and 3), and the heterozygous virus. In the
second viral replication cycle, the heterozygous virus infect a neighbor cell
and could produce a recombinant provirus, as shown in the bottom cell, as
the most frequent event (see Discussion) or again to the generation of two
different proviruses. The recombinant provirus will produce recombinant
virions with a wild-type genome responsible for the upper band in the gel.Discussion
In this report, we have studied if the two genomic RNA
present in HIV-1 virions could be used for the generation of
two different proviruses and two new viruses. The evidence
on the use of the two genomic RNAs has come from the
analysis of the proviral DNA from MT-4 plaques infected
with heterozygous viruses.
We designed an experimental system in order that the
only viable virions produced were heterozygous virions. To
this end, we constructed two deleterious mutants which after
co-transfection produced homozygous deleterious virions
and heterozygous virions. After infection of MT-4 cells
monolayer with this supernatant, we obtained plaques
displaying a single band corresponding to the wild-type
size and plaques with smaller bands corresponding to the
two deleterious variants (see Fig. 6).
The heterozygous virions could produce a plaque by two
different procedures: recombination between the two defec-
tive viral RNAs during the first retrotranscription cycle after
the infection, or by the complementation between the two
integrated defective provirus in the MT4 cells. The first
process relate in our experiment to the five plaques
(numbers 4, 5, 6, 7 and 8 in Fig. 6) showing the wild-
type band formed by recombination and the second
phenomenon with the plaques displaying multiple bands
(numbers 1, 2 and 3 in Fig. 6).
To study if the plaques with multiple bands could be the
result of the co-infection of one cell by two or three
viruses, we performed a double infection with two strains
from B and D subtypes and we analyzed by the plaque
assay. Among the 127 plaques obtained, we did not found
any co-infected cell as deduced from the absence of
recombinant viruses, but one double-infected plaque (see
Fig. 3A). From this experiment, the frequency of co-
infection was estimated to be lower than 1/127. But also,
in multiple previous MT-4 plaque assays performed with
two strains of different HIV-1 subtypes, we never obtained
cells co-infected with the two variants studied (Iglesias-
Sanchez and Lopez-Galindez, 2002) because recombinant
viruses were never detected in the progeny. All these
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multiple bands obtained in our experiment were the result
of co-infected cells.
Rather, as explained in the paragraph of the results
dealing with the differentiation of double-infected versus
co-infected plaques, plaques displaying multiple bands
correspond to the infection of two initial neighbor cells
included in the same visible plaque. But in our experimental
design, double-infected plaques with two defective genomes
are not viable. Also, the experimental conditions in which
the MT-4 plaque assay is carried out, co-infection is a very
infrequent event with a much lower probability than
bdouble-infected plaquesQ. Then if the co-infection of one
cell by two viruses could be excluded and the infection of
two neighbor cell will not produce a plaque, the only
remaining possibility for the plaques with three bands is the
retrotranscription of the two genomic RNAs and the
formation of two provirus. The generation of these three
plaques could consist in the following steps: (i) infection of
the initial cell of the plaque by a heterozygous virion,
reverse transcription of two the RNA strands and formation
of two proviral DNAs; (ii) replication of the two integrated
provirus and generation by complementation between the
two defective genomes of new heterozygous virions which
infect a neighbor cell; (iii) recombination during the
retrotranscription in this second infection cycle. All these
steps are summarized in Fig. 7.
It is important to try to quantify the frequency of the
usage of both genomic RNA strands resulting in the
formation of new viruses. This phenomenon could only
be observed when the two strands are intact and produce
infectious virions. In the transfection experiments with the
positive control plasmids, we have obtained around 1500
plaques (Fig. 5). We can estimate that the expected number
of virions in the supernatants of the co-transfection with the
two deleterious mutants should be similar to the number in
the control experiment. But we need to clarify that in an
ideal viral population where the two parental viruses are
equally expressed, and packaging is random, only 50% of
the virions will be heterozygous (Hu and Temin, 1990b).
Basically all these heterozygous virions would yield
recombinant provirus if the two genetic markers are wide
apart in the genome (Jetzt et al., 2000). This is the reason
why we constructed the two deleterious mutants with the
markers near each other. This strategy permitted to diminish
the screening from 750 to only 5 recombinant plaques.
Moreover, whereas the distance between the genetic
markers affect the generation of recombinant viruses it
did not have an effect on the phenomenon of the usage of
the two genomic RNA and in the generation of two new
provirus. As we detected 5 recombinant events in a
fragment of 450 nucleotides we could expect a 135
recombinants in the complete genome (Hu and Temin,
1990b; Linial and Brown, 1979; Jetzt et al., 2000, #1635;
Wyke et al., 1975). In our experiments we obtained
evidence on the use of the two genomic strains in 3 virusesout of 135 expected viruses (or 2.2%). Then, the frequency
of the usage of both genomic RNA is much lower than
recombination.
What are the biological consequences of this phenom-
enon? HIV-1 like all other RNA viruses has adopted a high
genetic variability as an evolutive strategy. HIV-1 genetic
variation is contributed by different mechanisms like point
mutation, genetic recombination, hypermutation, etc. . . The
high genetic variability has important advantages for the
adaptation to new environments (infection of new compart-
ments, resistance to antiviral therapy, tropism, etc. . .).
However on the other hand, HIV-1 is close to the error
catastrophe as shown by the incapacity of HIV to tolerate
many additional mutations without loss of viability (Coffin,
1995; Loeb et al., 1999). It is not known, however, how
vulnerable is the line that separates adaptation from
extinction and depending on the biology of the different
viral families this line could be very different (Domingo,
2000).
Retroviruses evolved different mechanisms to move
away from the error catastrophe. In particular, retroviruses
have selected for two complete copies of the genomic RNA
in each virion. This characteristic allows viruses to escape
away from the error catastrophe by a well-known mecha-
nism: recombination, but also as we describe in this work:
by reverse transcription of the two genomic RNAs. The
retrotranscription of the two genomic RNAs results in the
formation of heterozygous viruses which is the necessary
step in the generation of recombinant viruses. Moreover, by
the reverse transcription of both genomic strands, one HIV-1
virion carrying two defective RNAs genomes can become
viable. This phenomenon offers great advantages in
situations where enormous damages have been produced
in the viral genome (Inoue et al., 1991).
In summary, in an in HIV-1 in vitro system, we have
detected a new mechanism which based in the presence of
two genomic RNAs in the virion consist in the retrotran-
scription of the two genomic RNAs, formation of two
provirus and generation of different new virions. This
mechanism permits the recovery of deleterious mutants
and enhances the evolutive potential of HIV and other
retroviruses.Materials and methods
MT-4 plaque assay
Biological clones were obtained by the MT-4 plaque
assay from HIV-1 culture supernatants, as previously
described (Harada et al., 1985; Sanchez-Palomino et al.,
1993). Individual plaques were picked at random and
resuspended in 100 Al of complete medium and kept frozen
(70 8C) until analysis. DNAwas extracted from each clone
in 20 Al of medium following the manufacturer instruction
of the Instagene kit (Bio-Rad, CA, USA) instructions.
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Individual plaques were obtained from cultures per-
formed in liquid medium infected with two strains from
different HIV-1 subtypes. Recombinant viruses can be
differentiated from the parental virus belonging to HIV-1
subtypes, B (LAI strain) and D (strain 92UG24), by the
analysis of two genes, gag and env (Iglesias-Sanchez and
Lopez-Galindez, 2002), using the following PCR. In gag
gene, the primers used were as follows: 117GD (5V-
CCCCAGACCTGAAGCTCTCTT-3V nt 1748 to 1768)
and 118GU (5V-AGACAGGTTAATTTTTTAGGGAA-3V
nt 1618 to 1645), and in env gene 114EU (5V-TCCTCAG-
GAGGGGACCCAGAAA-3V, nt 6890 to 6912) and 115ED
(5V-TTTTATTCTGCATGGGAGGGTGAT-3V nt 7064 to
7040). The two primer pairs gave four amplicons of
different sizes that could be resolved in 5% acrylamide
gels. Primers derived from gag produced fragments of 152
nt for subtype B LAI strain and of 117 nt for subtype D
92UG24. The env amplification produced fragments of 176
nt from B virus and 167 nt for D strains (see Fig. 2).
Construction of plasmids
For the construction of the two deleterious mutants, we
utilized the pFAM4 plasmid corresponding to the 5V end of a
molecular clone obtained in our laboratory (Olivares et al.,
1998). Site-directed mutagenesis of plasmid pFAM4 in gag
gene was carried out using the QuickChange site-directed
mutagenesis kit as described by the manufacturer (Stra-
tagene). The primers used in the mutagenesis for the Dp6
deletion were 314GU 5V-CCTCAGAACAGACTAGAGC-
CACCTTCAGCTTCCCTCAAATCACTC-3V and 315GD
5V-GAGTGATTTGAGGGAAGCTGAAGGTGGCTC-
TAGTCTGTTCTGAGG-3. For the Dp24 mutant, primers
287GU 5V-CCGGTTCTATAAGACTCTGCATGCC-
GAGCAAGCTTCACAGGAGG-3V and 288GU 5V-
CCTCCTGTGAAGCTTGCTCGGCATGCAGAGTCTTA-
TAGAACCGG-3V were employed. Primers 314 and 315
produced a deletion of 99 nt (from residue 7 to residue 39)
in the p6 protein of pFAM4 after a PCR reaction performed
at 95 8C/30 s, 18 cycles of 95 8C/30 s, 52 8C/1 m, 68 8C/19
m, following a digestion with DpnI at 37 8C/1 h as
described in the QuickChange site-directed mutagenesis kit
(Stratagene). Primers 287 and 288 introduced four-point
mutations at positions 1250–1253 (LAI) of pFAM4 pro-
ducing an SphI site after a PCR reaction at 95 8C/30 s and
18 cycles of 95 8C/30 s, 55 8C/1 min, and 68 8C/19 min.
This plasmid was digested with SphI and ligated, producing
a deletion of 258 nt in p24 taking advantage of a natural
SphI site in positions 992–997. After digestion, the plasmid
was ligated and used for the transfections experiments. All
the changes introduced were confirmed by sequencing.
High amounts of plasmid DNA was recovered by the
WizardTM Maxipreps DNA purification Systems kit
(Promega).Transfection of Cos-1 cells
To obtain infectious viruses, plasmid pFAM4 or the
deleted constructs were cotransfected together with plasmid
Fc (Iglesias-Ussel et al., 2002; Olivares et al., 1998). Cos-1
cells were grown in RPMI 1640 (Bio-Whittaker) supple-
mented with 10% fetal bovine serum (Gibco) plus 1%
antibiotics (Bio-Whittaker). 10 Ag of each of the purified
plasmids was transfected into 4  106 Cos-1 cells by
electroporation on a Bio-Rad gene pulserII set at 975 AF
and 250 V. The following four combinations of plasmids
were used: (1) 10 Ag pFAM4 + 10 Al pFc; (2) 10 Ag
Dp24  pFAM4 + 10 Ag pFc; (3) 10 Ag Dp6  pFAM4 +
10 Ag pFc; (4) 10 Ag Dp24  pFAM4 + 10 Ag Dp6 
pFAM4 + 10 Ag pFc; and (5) 10 Ag Dp24  pFAM4 +
10 Ag Dp6  pFAM4 + 10 Ag pFc and a control experiment
with no DNA (see Fig. 5).
Supernatants from days 2, 4, 6, 8, 10, 12, and 14 were
harvested, clarified at 2500 rpm to remove cells, and ultra
centrifuged at 35,000 rpm for 2 h 20 min in an SW 40 rotor.
Pellets were resuspended in 1 ml of culture medium and
treated with DNase I RQ1 (RNase free, Promega) for 30 min
at 37 8C to digest the input plasmid, and plaqued in an MT-4
monolayer (Harada et al., 1985; Sanchez-Palomino et al.,
1993). MT-4 cells were kindly provided by Dr. D. Richman
(Department of Medicine and Pathology, UCSD). Plaques
were picked up with a p200 micropipette and resuspended
in 100 Al of culture medium, and 20 Al used for DNA
extraction with the help of the Instagene purification matrix
kit (Bio-Rad).
Analysis and characterization of proviral genomes from the
plaques
To differentiate the provirus obtained in the plaques
resulting from transfections, we analyzed the gag gene by
PCR. We used the following primers: 302GU 5V-CAGCAT-
TATCAGAAGGAGCCA (850–871) and 14RD 5V-CTATA-
GATTAGGGACCACAGAGT (2539–2560) for a first
amplification, and primers 303GU 5V-GGGACATCA-
AGCAGCCATGCAA (908–931) and 409D 5V-CCTT-
TAGTTGCCCCCCTATCT (1873–1893) for a second
amplification. PCR reactions were carried out for 35 cycles
of 35 s at 95 8C, 45 s at 52 8C, and 2 min at 72 8C, followed
by a 10-min last cycle of incubation at 72 8C. Three
amplicons were obtained corresponding to a fragment of
985 nt for the wild type, of 886 nt corresponding to the 99 nt
deletion in p6, and of 727 nt for the 258 nt in p24 deletion.
Analysis of the PCR products was performed in 0.9%
agarose TAE gels (40 mM Tris–acetate, 1 mM EDTA).Acknowledgments
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